{"id":24132,"date":"2016-01-28T17:32:51","date_gmt":"2016-01-28T16:32:51","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=24132"},"modified":"2016-01-28T17:34:04","modified_gmt":"2016-01-28T16:34:04","slug":"svizzera-farmaci-aumentano-le-vendite","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/svizzera-farmaci-aumentano-le-vendite\/","title":{"rendered":"Swiss. Drugs, sales increase"},"content":{"rendered":"<p><em>The share of generics on the market for medicines reimbursed by health insurance companies was 14.4%. Patent-protected drugs accounted for 52.3% of those reimbursed by basic insurance. After years of stagnation, the medicines market in Switzerland returned to growth in 2015.<\/em><\/p>\n<p>Article by <a href=\"mailto:cronaca@tio.ch\" target=\"_blank\">ats \/ p.d.a.<\/a>\u00a0&#8211;\u00a0<a href=\"http:\/\/www.tio.ch\/News\/Affari\/Borse-e-Mercati\/1067948\/Farmaci-aumentano-le-vendite\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">28\/01\/2016 \u2013 tio.ch<\/span><\/a><\/p>\n<p class=\"MarginTop0\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft\" src=\"http:\/\/media.tio.ch\/files\/images\/4bk1\/l_4m1n.jpg?v=1\" alt=\"\" width=\"455\" height=\"203\" \/>BERN \u2013 After years of stagnation, the medicines market in Switzerland returned to growth in 2015: compared to the previous year, sales increased by 5%. On the other hand, turnover fell by 2.8% due to the lowering of prices carried out in previous years, today indicate the Association of Pharmaceutical Companies in Switzerland (Vips) and Interpharma, which brings together companies in the sector that practice research.<\/p>\n<p>The drop in turnover could be mitigated by the introduction of new medicines and increased sales of more expensive packs.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright\" src=\"http:\/\/www.rsi.ch\/news\/svizzera\/In-crescita-anche-il-mercato-dei-medicinali-generici-6790772.html\/alternates\/LANDSCAPE_744\/In%20crescita%20anche%20il%20mercato%20dei%20medicinali%20generici\" alt=\"\" width=\"325\" height=\"182\" \/>The market for medicines reimbursed by health insurance companies grew by 6.3% to 4.43 billion francs. Pharmacies accounted for 50.9% of this market, doctor&#039;s offices 26% and hospitals 23.1%. The former \u2013 the note specifies \u2013 recorded the strongest growth (+7.2%).<\/p>\n<p>Antiviral medicines recorded the sharpest growth in value (+47.5%), following the introduction of new hepatitis C drugs. The generics market continued to progress (+3.2%) to stand at 636 .7 million francs. The share of generics on the market for medicines reimbursed by health insurance companies was 14.4%.<\/p>\n<p>Patent-protected drugs accounted for 52.3% of those reimbursed by basic insurance. In terms of value, they recorded a growth of 9.5%, while in volume they were less distributed.<\/p>\n<p><em>ats<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>La parte dei generici sul mercato dei medicinali rimborsati dalle case malattie \u00e8 stata del 14,4%.\u00a0I farmaci protetti dal brevetto hanno rappresentato il 52,3% di quelli rimborsati dall&#8217;assicurazione di base.\u00a0Dopo anni di stagnazione, nel 2015 \u00e8 tornato a crescere il mercato dei medicinali in Svizzera. Articolo di ats \/ p.d&#8217;a.\u00a0&#8211;\u00a028\/01\/2016 &#8211; tio.ch BERNA &#8211; Dopo &hellip;<\/p>","protected":false},"author":4,"featured_media":5602,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[26],"class_list":["post-24132","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-spesa-farmaceutica"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/24132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=24132"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/24132\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/5602"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=24132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=24132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=24132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}